BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 16751189)

  • 21. Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer's disease pathogenesis.
    Velliquette RA; O'Connor T; Vassar R
    J Neurosci; 2005 Nov; 25(47):10874-83. PubMed ID: 16306400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PAR-4 is involved in regulation of beta-secretase cleavage of the Alzheimer amyloid precursor protein.
    Xie J; Guo Q
    J Biol Chem; 2005 Apr; 280(14):13824-32. PubMed ID: 15671026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amyloid-β protein (Aβ) Glu11 is the major β-secretase site of β-site amyloid-β precursor protein-cleaving enzyme 1(BACE1), and shifting the cleavage site to Aβ Asp1 contributes to Alzheimer pathogenesis.
    Deng Y; Wang Z; Wang R; Zhang X; Zhang S; Wu Y; Staufenbiel M; Cai F; Song W
    Eur J Neurosci; 2013 Jun; 37(12):1962-9. PubMed ID: 23773065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer's disease pathogenesis.
    Zhao J; Fu Y; Yasvoina M; Shao P; Hitt B; O'Connor T; Logan S; Maus E; Citron M; Berry R; Binder L; Vassar R
    J Neurosci; 2007 Apr; 27(14):3639-49. PubMed ID: 17409228
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Altered amyloid-beta metabolism and deposition in genomic-based beta-secretase transgenic mice.
    Chiocco MJ; Kulnane LS; Younkin L; Younkin S; Evin G; Lamb BT
    J Biol Chem; 2004 Dec; 279(50):52535-42. PubMed ID: 15452128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutant presenilin 2 increases β-secretase activity through reactive oxygen species-dependent activation of extracellular signal-regulated kinase.
    Park MH; Choi DY; Jin HW; Yoo HS; Han JY; Oh KW; Han SB; Hwang DY; Hong JT
    J Neuropathol Exp Neurol; 2012 Feb; 71(2):130-9. PubMed ID: 22249458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is Sirt1 a miracle bullet for longevity?
    Imai S
    Aging Cell; 2007 Dec; 6(6):735-7. PubMed ID: 17941969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein.
    Obregon DF; Rezai-Zadeh K; Bai Y; Sun N; Hou H; Ehrhart J; Zeng J; Mori T; Arendash GW; Shytle D; Town T; Tan J
    J Biol Chem; 2006 Jun; 281(24):16419-27. PubMed ID: 16624814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of Early Growth Response 1 in the Hippocampus Alleviates Neuropathology and Improves Cognition in an Alzheimer Model with Plaques and Tangles.
    Qin X; Wang Y; Paudel HK
    Am J Pathol; 2017 Aug; 187(8):1828-1847. PubMed ID: 28641077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SIRT1 and neuronal diseases.
    Tang BL; Chua CE
    Mol Aspects Med; 2008 Jun; 29(3):187-200. PubMed ID: 17397914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SIRT1 and caloric restriction: an insight into possible trade-offs between robustness and frailty.
    Imai S
    Curr Opin Clin Nutr Metab Care; 2009 Jul; 12(4):350-6. PubMed ID: 19474721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phosphorylation regulates SIRT1 function.
    Sasaki T; Maier B; Koclega KD; Chruszcz M; Gluba W; Stukenberg PT; Minor W; Scrable H
    PLoS One; 2008; 3(12):e4020. PubMed ID: 19107194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease.
    Culbert AA; Skaper SD; Howlett DR; Evans NA; Facci L; Soden PE; Seymour ZM; Guillot F; Gaestel M; Richardson JC
    J Biol Chem; 2006 Aug; 281(33):23658-67. PubMed ID: 16774924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Carbon monoxide attenuates amyloidogenesis via down-regulation of NF-κB-mediated BACE1 gene expression.
    Kim HJ; Joe Y; Chen Y; Park GH; Kim UH; Chung HT
    Aging Cell; 2019 Feb; 18(1):e12864. PubMed ID: 30411846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tissue-specific regulation of SIRT1 by calorie restriction.
    Chen D; Bruno J; Easlon E; Lin SJ; Cheng HL; Alt FW; Guarente L
    Genes Dev; 2008 Jul; 22(13):1753-7. PubMed ID: 18550784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rho-associated protein kinase 1 (ROCK1) is increased in Alzheimer's disease and ROCK1 depletion reduces amyloid-β levels in brain.
    Henderson BW; Gentry EG; Rush T; Troncoso JC; Thambisetty M; Montine TJ; Herskowitz JH
    J Neurochem; 2016 Aug; 138(4):525-31. PubMed ID: 27246255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoamine oxidase B is elevated in Alzheimer disease neurons, is associated with γ-secretase and regulates neuronal amyloid β-peptide levels.
    Schedin-Weiss S; Inoue M; Hromadkova L; Teranishi Y; Yamamoto NG; Wiehager B; Bogdanovic N; Winblad B; Sandebring-Matton A; Frykman S; Tjernberg LO
    Alzheimers Res Ther; 2017 Aug; 9(1):57. PubMed ID: 28764767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibitors of Rho-kinase modulate amyloid-beta (Abeta) secretion but lack selectivity for Abeta42.
    Leuchtenberger S; Kummer MP; Kukar T; Czirr E; Teusch N; Sagi SA; Berdeaux R; Pietrzik CU; Ladd TB; Golde TE; Koo EH; Weggen S
    J Neurochem; 2006 Jan; 96(2):355-65. PubMed ID: 16300630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain.
    Dovey HF; John V; Anderson JP; Chen LZ; de Saint Andrieu P; Fang LY; Freedman SB; Folmer B; Goldbach E; Holsztynska EJ; Hu KL; Johnson-Wood KL; Kennedy SL; Kholodenko D; Knops JE; Latimer LH; Lee M; Liao Z; Lieberburg IM; Motter RN; Mutter LC; Nietz J; Quinn KP; Sacchi KL; Seubert PA; Shopp GM; Thorsett ED; Tung JS; Wu J; Yang S; Yin CT; Schenk DB; May PC; Altstiel LD; Bender MH; Boggs LN; Britton TC; Clemens JC; Czilli DL; Dieckman-McGinty DK; Droste JJ; Fuson KS; Gitter BD; Hyslop PA; Johnstone EM; Li WY; Little SP; Mabry TE; Miller FD; Audia JE
    J Neurochem; 2001 Jan; 76(1):173-81. PubMed ID: 11145990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of 6-mo caloric restriction on myocardial ischemic tolerance: possible involvement of nitric oxide-dependent increase in nuclear Sirt1.
    Shinmura K; Tamaki K; Bolli R
    Am J Physiol Heart Circ Physiol; 2008 Dec; 295(6):H2348-55. PubMed ID: 18931029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.